These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29201725)

  • 1. Past, Present, and Future of Viral Hepatitis C in Japan.
    Yatsuhashi H
    Euroasian J Hepatogastroenterol; 2016; 6(1):49-51. PubMed ID: 29201725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease.
    Kanto T; Yoshio S
    Euroasian J Hepatogastroenterol; 2017; 7(1):60-64. PubMed ID: 29201774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Hepatitis in Mongolia: Past, Present, and Future.
    Tsatsralt-Od B
    Euroasian J Hepatogastroenterol; 2016; 6(1):56-58. PubMed ID: 29201727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past, Present, and Future of Viral Hepatitis in Bangladesh.
    Mamun-Al-Mahtab
    Euroasian J Hepatogastroenterol; 2016; 6(1):43-44. PubMed ID: 29201723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Hepatitis in Pakistan: Past, Present, and Future.
    Butt AS; Sharif F
    Euroasian J Hepatogastroenterol; 2016; 6(1):70-81. PubMed ID: 29201731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing Etiology in Liver Cirrhosis in Sapporo, Japan.
    Kang JH; Matsui T
    Euroasian J Hepatogastroenterol; 2018; 8(1):77-80. PubMed ID: 29963470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Viral Hepatitis and Liver Diseases in Pakistan.
    Butt AS
    Euroasian J Hepatogastroenterol; 2015; 5(1):43-48. PubMed ID: 29201686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral Hepatitis in Nepal: Past, Present, and Future.
    Shrestha A
    Euroasian J Hepatogastroenterol; 2016; 6(1):59-61. PubMed ID: 29201728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral Hepatitis in Cambodia: Past, Present, and Future.
    Sreng B; Sophal C; Srun S; Samnang C; Huot E
    Euroasian J Hepatogastroenterol; 2016; 6(1):45-48. PubMed ID: 29201724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan.
    Igarashi A; Tang W; Cure S; Guerra I; Marié L; Lopresti M; Tsutani K
    Curr Med Res Opin; 2017 Jan; 33(1):1-10. PubMed ID: 27608157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine.
    Laugi H
    Euroasian J Hepatogastroenterol; 2020; 10(2):105-108. PubMed ID: 33511075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Hepatitis in Korea: Past, Present, and Future.
    Lee HS
    Euroasian J Hepatogastroenterol; 2016; 6(1):62-64. PubMed ID: 29201729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Viral Hepatitis and Liver Diseases in Mongolia.
    Tsatsralt Od B
    Euroasian J Hepatogastroenterol; 2015; 5(1):37-39. PubMed ID: 29201684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Treatment of Acute and Chronic Hepatitis E Virus Infection: Role of Antivirals.
    Shrestha A; P Gupta B; K Lama T
    Euroasian J Hepatogastroenterol; 2017; 7(1):73-77. PubMed ID: 29201777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Hepatitis B and C Virus Infections and Liver Cancer in Vietnam.
    Huy Do S
    Euroasian J Hepatogastroenterol; 2015; 5(1):49-51. PubMed ID: 29201687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of Hepatitis Viruses: Bangladesh Scenario.
    Al Mahtab M
    Euroasian J Hepatogastroenterol; 2017; 7(1):40-42. PubMed ID: 29201770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Viral Hepatitis and Liver Diseases in Bangladesh.
    Mahtab MA
    Euroasian J Hepatogastroenterol; 2015; 5(1):26-29. PubMed ID: 29201681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b.
    McEwan P; Ward T; Webster S; Yuan Y; Kalsekar A; Broglio K; Kamae I; Quintana M; Berry SM; Kobayashi M; Inoue S; Tang A; Kumada H
    Value Health Reg Issues; 2014 May; 3():136-145. PubMed ID: 29702919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
    Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P
    World J Gastroenterol; 2015 May; 21(18):5647-53. PubMed ID: 25987791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.